• In January 2026, Morningstar, Inc. rolled out the Morningstar PitchBook GenAI 20 Index, renewed its role as index provider for PIMFA’s rebranded private investor and equity risk benchmarks, and released new retirement research on managed accounts through its Center for Retirement & Policy Studies.
• Together, these moves underline Morningstar’s push to link cutting-edge generative AI exposure, industry-standard wealth management benchmarks, and data-driven retirement insights into an integrated research and indexing platform.
• Next, we’ll examine how Morningstar’s push into pure-play generative AI indexing reshapes the company’s investment narrative for long-term investors.

The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

What Is Morningstar's Investment Narrative?

For someone owning Morningstar, the big picture is about trusting its data, research and indexing engine to keep pulling more weight across wealth, retirement and private markets. Recent launches like the PitchBook GenAI 20 Index and the PIMFA benchmark deal fit that story neatly, reinforcing Morningstar’s role at the center of advice, benchmarking and analytics rather than transforming it overnight. With earnings and revenue still growing, near term catalysts remain tied to deeper adoption of its platforms and successful monetisation of index and AI capabilities, rather than any single product launch. The main risk is that Morningstar is paying a premium to be at the cutting edge just as the share price has lagged, so management still has to prove that these new AI and retirement initiatives translate into durable, profitable growth.

Yet there is a less obvious risk here that current shareholders should not ignore.

Morningstar's share price has been on the slide but might be dropping deeper into value territory. Find out whether it's a bargain at this price.

Exploring Other Perspectives

Eight fair value estimates from the Simply Wall St Community span roughly US$100 to a very large US$596, underscoring how far apart individual expectations sit. When you set that dispersion against Morningstar’s push into GenAI indexing and expanded benchmarks, it underlines why you may want to weigh several contrasting views on how much those initiatives can really move the needle.

Explore 8 other fair value estimates on Morningstar - why the stock might be worth less than half the current price!

Build Your Own Morningstar Narrative

Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Morningstar research is our analysis highlighting 4 key rewards that could impact your investment decision.
• Our free Morningstar research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Morningstar's overall financial health at a glance.

No Opportunity In Morningstar?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.
• Rare earth metals are the new gold rush. Find out which 32 stocks are leading the charge.
• This technology could replace computers: discover 23 stocks that are working to make quantum computing a reality.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.